<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02460601</url>
  </required_header>
  <id_info>
    <org_study_id>LCMSBL-09006</org_study_id>
    <nct_id>NCT02460601</nct_id>
  </id_info>
  <brief_title>The Efficacy and Safety of Qizhiweitong Granule on Patients With Functional Dyspepsia in a Multi-center Clinical Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wuhan Union Hospital, China</source>
  <brief_summary>
    <textblock>
      The study aims to verify the efficacy and safety of Qizhiweitong granule on Chinese patients
      with functional dyspepsia diagnosed by the Rome III criteria. It includes two subtypes of
      functional dyspepsia, postprandial distress syndrome or abdominal pain syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>symptom severity score</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Functional Dyspepsia</condition>
  <arm_group>
    <arm_group_label>Qizhiweitong granule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.5g/time,tid,oral administration,6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2.5g/time,tid,oral administration,6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Qizhiweitong granule</intervention_name>
    <arm_group_label>Qizhiweitong granule</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patient with written ICF signed

          2. patient with functional dyspepsia diagnosed by the Rome III criteria

          3. age between 18y and 65y;male or female.

          4. patient without gastric ulcers, erosive gastritis or other gastric organic diseases
             according to the endoscopy in the past one year in the hospital

          5. patient without hepatobiliary and pancreatic diseases according to B-ultrasoundin the
             past one year in the hospital

          6. patient with normal ECG (QT interval in the normal range) within one month prior to
             enrollment in this center

          7. patient with symptoms of only one subtype of functional dyspepsia

        Exclusion Criteria:

          1. history of abdominal surgery;

          2. take drugs related to gastrointestinal motility or gastric acid secretion and gastric
             acid drugs, anti-Helicobacter pylori drugs within 5 days of inclusion

          3. suffering from hepatobiliary and pancreatic diseases with B ultrasound

          4. suffering from high blood pressure and uncontroled hypertension

          5. diabetes mellitus

          6. have history of thyroid disease, systemic sclerosis, systemic lupus erythematosus

          7. severe mental disorders

          8. pregnant women, breastfeeding women or those who plan to become pregnant

          9. allergy to Qizhiweitong particle

         10. have symptoms of both subtypes of functional dyspepsia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2015</study_first_submitted>
  <study_first_submitted_qc>June 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2015</study_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wuhan Union Hospital, China</investigator_affiliation>
    <investigator_full_name>Zhongcheng Duan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspepsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

